BCA
XBI icon

Bray Capital Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bray Capital Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$843K Hold
9,360
– – 0.23% 84
2024
Q3 		$925K Sell
9,360
-550
-6% -$54K 0.23% 84
2024
Q2 		$919K Sell
9,910
-250
-2% -$22.4K 0.23% 81
2024
Q1 		$964K Hold
10,160
– – 0.24% 84
2023
Q4 		$907K Sell
10,160
-1,170
-10% -$86.9K 0.25% 84
2023
Q3 		$827K Hold
11,330
– – 0.25% 84
2023
Q2 		$943K Sell
11,330
-145
-1% -$12.1K 0.28% 81
2023
Q1 		$875K Hold
11,475
– – 0.26% 81
2022
Q4 		$952K Sell
11,475
-1,465
-11% -$119K 0.3% 78
2022
Q3 		$1.03M Hold
12,940
– – 0.32% 77
2022
Q2 		$961K Sell
12,940
-630
-5% -$47.3K 0.29% 87
2022
Q1 		$1.22M Buy
13,570
+2,460
+22% +$227K 0.31% 75
2021
Q4 		$1.24M Sell
11,110
-1,300
-10% -$157K 0.3% 71
2021
Q3 		$1.56M Hold
12,410
– – 0.4% 64
2021
Q2 		$1.68M Buy
12,410
+445
+4% +$58.5K 0.43% 62
2021
Q1 		$1.62M Buy
11,965
+710
+6% +$106K 0.45% 63
2020
Q4 		$1.58M Buy
11,255
+130
+1% +$16.7K 0.46% 58
2020
Q3 		$1.24M Sell
11,125
-15
-0.1% -$1.68K 0.44% 58
2020
Q2 		$1.25M Hold
11,140
– – 0.48% 57
2020
Q1 		$863K Sell
11,140
-200
-2% -$17.7K 0.4% 62
2019
Q4 		$1.08M Hold
11,340
– – 0.38% 66
2019
Q3 		$865K Hold
11,340
– – 0.34% 69
2019
Q2 		$995K Hold
11,340
– – 0.38% 69
2019
Q1 		$1.03M Buy
11,340
+850
+8% +$72.3K 0.43% 62
2018
Q4 		$753K Buy
10,490
+1,855
+21% +$149K 0.38% 65
2018
Q3 		$828K Hold
8,635
– – 0.37% 64
2018
Q2 		$822K Hold
8,635
– – 0.38% 62
2018
Q1 		$758K Hold
8,635
– – 0.35% 63
2017
Q4 		$733K Sell
8,635
-6,975
-45% -$584K 0.35% 66
2017
Q3 		$1.35M Hold
15,610
– – 0.71% 52
2017
Q2 		$1.21M Buy
15,610
+8,525
+120% +$605K 0.66% 54
2017
Q1 		$491K Sell
7,085
-560
-7% -$37.6K 0.28% 68
2016
Q4 		$453K Buy
+7,645
New +$472K 0.27% 74

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Bray Capital Advisors's XBI Position: Q4 2024 in Review

Bray Capital Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q4 2024 at 9,360 shares worth $843K. The position accounts for 0.23% of the portfolio, ranked #84.

Bray Capital Advisors first reported a position in XBI in Q4 2016 and has held it in 33 quarters since. The position peaked at $1.68M in Q2 2021. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

  • Bray Capital Advisors held 9,360 shares of State Street SPDR S&P Biotech ETF worth $843K as of Q4 2024.
  • Bray Capital Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q4 2024.
  • State Street SPDR S&P Biotech ETF made up 0.23% of Bray Capital Advisors's portfolio in Q4 2024, its #84 holding.
  • Bray Capital Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 33 quarters since.
  • Bray Capital Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.68M in Q2 2021.
  • 738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.